3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
54,093
|
44,713
|
|
|
|
受取手形、売掛金及び契約資産
|
21,178
|
19,378
|
|
|
|
有価証券
|
15,992
|
5,992
|
|
|
|
商品及び製品
|
8,805
|
7,567
|
|
|
|
仕掛品
|
2,311
|
2,578
|
|
|
|
原材料及び貯蔵品
|
7,904
|
8,970
|
|
|
|
未収還付法人税等
|
120
|
2,068
|
|
|
|
未収消費税等
|
70
|
1,302
|
|
|
|
その他
|
915
|
1,478
|
|
|
|
貸倒引当金
|
△0
|
-
|
|
|
|
流動資産合計
|
111,393
|
94,051
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
44,001
|
44,695
|
|
|
|
|
|
減価償却累計額
|
△28,470
|
△28,914
|
|
|
|
|
|
建物及び構築物(純額)
|
15,530
|
15,780
|
|
|
|
|
機械装置及び運搬具
|
17,181
|
19,325
|
|
|
|
|
|
減価償却累計額
|
△14,689
|
△14,549
|
|
|
|
|
|
機械装置及び運搬具(純額)
|
2,491
|
4,775
|
|
|
|
|
工具、器具及び備品
|
8,760
|
9,069
|
|
|
|
|
|
減価償却累計額
|
△7,049
|
△7,084
|
|
|
|
|
|
工具、器具及び備品(純額)
|
1,711
|
1,984
|
|
|
|
|
土地
|
3,867
|
2,676
|
|
|
|
|
建設仮勘定
|
4,027
|
1,916
|
|
|
|
|
有形固定資産合計
|
27,629
|
27,134
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
5,459
|
5,399
|
|
|
|
|
販売権
|
10,467
|
12,201
|
|
|
|
|
仕掛研究開発
|
5,446
|
5,495
|
|
|
|
|
その他
|
854
|
1,195
|
|
|
|
|
無形固定資産合計
|
22,228
|
24,291
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
18,875
|
18,730
|
|
|
|
|
長期前払費用
|
4,352
|
3,091
|
|
|
|
|
退職給付に係る資産
|
4,159
|
4,846
|
|
|
|
|
繰延税金資産
|
4,065
|
5,367
|
|
|
|
|
その他
|
674
|
704
|
|
|
|
|
投資その他の資産合計
|
32,126
|
32,740
|
|
|
|
固定資産合計
|
81,984
|
84,166
|
|
|
資産合計
|
193,377
|
178,217
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
8,186
|
7,428
|
|
|
|
電子記録債務
|
136
|
138
|
|
|
|
短期借入金
|
3,850
|
3,850
|
|
|
|
未払金
|
6,311
|
4,310
|
|
|
|
未払費用
|
1,145
|
1,516
|
|
|
|
未払法人税等
|
7,285
|
248
|
|
|
|
賞与引当金
|
1,154
|
1,019
|
|
|
|
役員賞与引当金
|
86
|
55
|
|
|
|
その他
|
2,198
|
2,236
|
|
|
|
流動負債合計
|
30,354
|
20,803
|
|
|
固定負債
|
|
|
|
|
|
従業員株式給付引当金
|
-
|
61
|
|
|
|
株式給付引当金
|
163
|
196
|
|
|
|
退職給付に係る負債
|
4,954
|
4,716
|
|
|
|
繰延税金負債
|
4,469
|
4,405
|
|
|
|
その他
|
800
|
414
|
|
|
|
固定負債合計
|
10,388
|
9,794
|
|
|
負債合計
|
40,742
|
30,597
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
23,853
|
23,853
|
|
|
|
資本剰余金
|
12,932
|
11,406
|
|
|
|
利益剰余金
|
135,242
|
125,625
|
|
|
|
自己株式
|
△28,233
|
△23,776
|
|
|
|
株主資本合計
|
143,794
|
137,109
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
6,257
|
6,806
|
|
|
|
為替換算調整勘定
|
△57
|
754
|
|
|
|
退職給付に係る調整累計額
|
2,640
|
2,949
|
|
|
|
その他の包括利益累計額合計
|
8,840
|
10,509
|
|
|
純資産合計
|
152,635
|
147,619
|
|
負債純資産合計
|
193,377
|
178,217
|
E00935
45210
科研製薬株式会社
KAKEN PHARMACEUTICAL CO., LTD.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
45210
2026-05-13
45210
2025-04-01
2026-03-31
45210
2025-04-01
2026-03-31
jppfs_cor:CapitalStockMember
45210
2025-04-01
2026-03-31
jppfs_cor:CapitalSurplusMember
45210
2025-04-01
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45210
2025-04-01
2026-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
45210
2025-04-01
2026-03-31
jpcrp_cor:ReconcilingItemsMember
45210
2025-04-01
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45210
2025-04-01
2026-03-31
jpcrp_cor:ReportableSegmentsMember
45210
2025-04-01
2026-03-31
jppfs_cor:RetainedEarningsMember
45210
2025-04-01
2026-03-31
jppfs_cor:ShareholdersEquityMember
45210
2025-04-01
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45210
2025-04-01
2026-03-31
jppfs_cor:TreasuryStockMember
45210
2025-04-01
2026-03-31
tse-acedjpfr-45210:MedicineReportableSegmentsMember
45210
2025-04-01
2026-03-31
tse-acedjpfr-45210:RealEstateReportableSegmentsMember
45210
2025-04-01
2026-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
45210
2025-04-01
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45210
2025-04-01
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45210
2026-03-31
45210
2026-03-31
jppfs_cor:CapitalStockMember
45210
2026-03-31
jppfs_cor:CapitalSurplusMember
45210
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45210
2026-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
45210
2026-03-31
jpcrp_cor:ReconcilingItemsMember
45210
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45210
2026-03-31
jpcrp_cor:ReportableSegmentsMember
45210
2026-03-31
jppfs_cor:RetainedEarningsMember
45210
2026-03-31
jppfs_cor:ShareholdersEquityMember
45210
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45210
2026-03-31
jppfs_cor:TreasuryStockMember
45210
2026-03-31
tse-acedjpfr-45210:MedicineReportableSegmentsMember
45210
2026-03-31
tse-acedjpfr-45210:RealEstateReportableSegmentsMember
45210
2026-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
45210
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45210
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45210
2024-04-01
2025-03-31
45210
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
45210
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
45210
2024-04-01
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45210
2024-04-01
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
45210
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
45210
2024-04-01
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45210
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
45210
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
45210
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
45210
2024-04-01
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45210
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
45210
2024-04-01
2025-03-31
tse-acedjpfr-45210:MedicineReportableSegmentsMember
45210
2024-04-01
2025-03-31
tse-acedjpfr-45210:RealEstateReportableSegmentsMember
45210
2024-04-01
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
45210
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45210
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45210
2025-03-31
45210
2025-03-31
jppfs_cor:CapitalStockMember
45210
2025-03-31
jppfs_cor:CapitalSurplusMember
45210
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45210
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
45210
2025-03-31
jpcrp_cor:ReconcilingItemsMember
45210
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45210
2025-03-31
jpcrp_cor:ReportableSegmentsMember
45210
2025-03-31
jppfs_cor:RetainedEarningsMember
45210
2025-03-31
jppfs_cor:ShareholdersEquityMember
45210
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
45210
2025-03-31
jppfs_cor:TreasuryStockMember
45210
2025-03-31
tse-acedjpfr-45210:MedicineReportableSegmentsMember
45210
2025-03-31
tse-acedjpfr-45210:RealEstateReportableSegmentsMember
45210
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
45210
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45210
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
45210
2024-03-31
45210
2024-03-31
jppfs_cor:CapitalStockMember
45210
2024-03-31
jppfs_cor:CapitalSurplusMember
45210
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
45210
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
45210
2024-03-31
jppfs_cor:RetainedEarningsMember
45210
2024-03-31
jppfs_cor:ShareholdersEquityMember
45210
2024-03-31
jppfs_cor:TreasuryStockMember
45210
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
45210
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure